Key result
Thrombophilia testing aims to optimize anticoagulant benefit-risk by predicting VTE recurrence.
Design
Review
Authors
Loading...
Thrombophilia testing may aid VTE risk stratification for anticoagulation decisions; leaves open its net clinical benefit pending prospective validation.
Thrombophilia testing may help distinguish patients at high and low risk of thrombosis to optimize the risk-benefit ratio of anticoagulant treatment.
Trevor Baglin (2000) conducted a review in Inherited thrombophilia and venous thromboembolism. Thrombophilia testing was evaluated. Thrombophilia testing aims to optimize the benefit-risk ratio of anticoagulant treatment by predicting the likelihood of venous thromboembolism recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: